Overview

3-year Follow-up Study to Assess the Viral Activity in Hepatitis C Patients Who Failed Feeder DEB025/Alisporivir Study

Status:
Terminated
Trial end date:
2014-01-23
Target enrollment:
Participant gender:
Summary
Follow-up for viral activity, changes in liver function and safety in patients with no SVR24 in feeder studies
Phase:
Phase 3
Details
Lead Sponsor:
Novartis Pharmaceuticals